Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
15.74
+0.24 (1.55%)
At close: Feb 6, 2026
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $27.85 billion as of February 6, 2026. Its market cap has increased by 62.14% in one year.
Market Cap
27.85B
Enterprise Value
30.86B
Revenue
13.14B
Ranking
n/a
PE Ratio
13.52
Stock Price
$15.74
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 27.85B, an increase of 299.99%. That is a compound annual growth rate of 4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 27.85B | 16.09% |
| Dec 30, 2025 | 23.99B | 37.26% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 756.71M |
| Elite Pharmaceuticals | 481.05M |
| Northwest Biotherapeutics | 405.51M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 317.38M |
| OpGen | 310.55M |